A database of pediatric drug effects to evaluate ontogenic mechanisms from child growth and development.

Author: GiangrecoNicholas P, TatonettiNicholas P

Paper Details 
Original Abstract of the Article :
Adverse drug effects (ADEs) in children are common and may result in disability and death, necessitating post-marketing monitoring of their use. Evaluating drug safety is especially challenging in children due to the processes of growth and maturation, which can alter how children respond to treatme...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/35752163

データ提供:米国国立医学図書館(NLM)

A Database of Pediatric Drug Effects: Navigating the Shifting Sands of Childhood Development

The world of drug safety is a complex and ever-changing landscape, particularly for children. This study highlights the critical importance of developing a dedicated database to track and evaluate the effects of medications on children, taking into account their unique developmental trajectories. Think of it as a mapmaker meticulously charting the ever-shifting sands of childhood development, ensuring a safer path for young patients. This research is like a camel caravan traversing the vast desert, carefully mapping the terrain to ensure safe passage for its precious cargo.

Tailoring Treatments for Children

The research recognizes the crucial need for tailored treatment approaches for children, considering their distinct physiology and development. This is akin to a desert nomad carefully adjusting their strategy based on the specific challenges of the terrain.

The Need for Pediatric-Specific Drug Safety Data

This study underscores the necessity of a specialized database dedicated to pediatric drug safety, a beacon in the often-uncharted territory of medication effects in children. This database would serve as a vital resource for researchers, clinicians, and parents, providing a comprehensive understanding of drug safety and efficacy in pediatric populations.

Dr. Camel's Conclusion

This study emphasizes the importance of prioritizing research and data collection specific to pediatric drug safety. Just as a wise camel knows the importance of navigating the desert with caution, we must carefully consider the unique needs of children when it comes to medication use. The development of a dedicated database for pediatric drug effects is a vital step towards ensuring the safety and well-being of young patients.
Date :
  1. Date Completed 2022-08-16
  2. Date Revised 2023-08-13
Further Info :

Pubmed ID

35752163

DOI: Digital Object Identifier

NIHMS1819585

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.